Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccines

Showing results (511-520 of 10,021) with videos related to

Pageof 1,003
Sort By:
Vaccines|December 11, 2019
Yellow Fever Virus Genotyping Tool and Investigation of Suspected Adverse Events Following Yellow Fever VaccinationIzabela Maurício de Rezende, Pedro Augusto Alves, Matheus Soares Arruda, et al.
Vaccines|December 11, 2019
Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre-Lox System for Construction of a Stable Vaccine VectorMustafa Ozan Atasoy, Mohammed A Rohaim, Muhammad Munir
Vaccines|February 7, 2020
Protective Immunity Elicited by VP1 Chimeric Antigens of Bacterial Ghosts against Hand-Foot-and-Mouth Disease VirusSaisai Gong, Nan Nan, Yakun Sun, et al.
Vaccines|February 9, 2020
RNA Sensing of <i>Mycobacterium tuberculosis</i> and Its Impact on TB Vaccination StrategiesSanne Burkert, Ralf R Schumann
Vaccines|March 6, 2020
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community-Spain (2008-2018)Cecilia M Egoavil, José Tuells, Juan José Carreras, et al.
Vaccines|February 21, 2020
Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last DecadeMarco Montalti, Anna Kawalec, Erica Leoni, et al.
Vaccines|February 21, 2020
Targeted Delivery of Mannosylated Nanoparticles Improve Prophylactic Efficacy of Immersion Vaccine against Fish Viral DiseaseBin Zhu, Chen Zhang, Zhao Zhao, et al.
Vaccines|January 23, 2020
Surface Immunogenic Protein of <i>Streptococcus</i> Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune AdjuvantDiego A Diaz-Dinamarca, Ricardo A Manzo, Daniel A Soto, et al.
Vaccines|January 24, 2020
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine DevelopmentPeter A C Maple
Vaccines|December 15, 2018
Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent VaccineEls van Westen, Mirjam J Knol, Alienke J Wijmenga-Monsuur, et al.
Pageof 1,003

Showing results (511-520 of 10,021) with videos related to

Sort By:
Pageof 1,003
Vaccines|December 11, 2019
Yellow Fever Virus Genotyping Tool and Investigation of Suspected Adverse Events Following Yellow Fever VaccinationIzabela Maurício de Rezende, Pedro Augusto Alves, Matheus Soares Arruda, et al.
Vaccines|December 11, 2019
Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre-Lox System for Construction of a Stable Vaccine VectorMustafa Ozan Atasoy, Mohammed A Rohaim, Muhammad Munir
Vaccines|February 7, 2020
Protective Immunity Elicited by VP1 Chimeric Antigens of Bacterial Ghosts against Hand-Foot-and-Mouth Disease VirusSaisai Gong, Nan Nan, Yakun Sun, et al.
Vaccines|February 9, 2020
RNA Sensing of <i>Mycobacterium tuberculosis</i> and Its Impact on TB Vaccination StrategiesSanne Burkert, Ralf R Schumann
Vaccines|March 6, 2020
Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community-Spain (2008-2018)Cecilia M Egoavil, José Tuells, Juan José Carreras, et al.
Vaccines|February 21, 2020
Measles Immunization Policies and Vaccination Coverage in EU/EEA Countries over the Last DecadeMarco Montalti, Anna Kawalec, Erica Leoni, et al.
Vaccines|February 21, 2020
Targeted Delivery of Mannosylated Nanoparticles Improve Prophylactic Efficacy of Immersion Vaccine against Fish Viral DiseaseBin Zhu, Chen Zhang, Zhao Zhao, et al.
Vaccines|January 23, 2020
Surface Immunogenic Protein of <i>Streptococcus</i> Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune AdjuvantDiego A Diaz-Dinamarca, Ricardo A Manzo, Daniel A Soto, et al.
Vaccines|January 24, 2020
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine DevelopmentPeter A C Maple
Vaccines|December 15, 2018
Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent VaccineEls van Westen, Mirjam J Knol, Alienke J Wijmenga-Monsuur, et al.
Pageof 1,003